Fufang Danshen Pian (danshen Tablets) Ameliorates Myocardial Infarction Injury Via Endothelial Protection in Rats
Pan Jian-Hao,Wenjuan Fu,Jun Lin,Wei-chung Luo,Chuyuan Li,Deqin Wang,Jing-sen Zhang,Pin-quan Li,Guang Hong,Shangdong Liang,Renan Qin,Wenyan Liu,Hong Nie
2017-01-01
Journal of Pharmaceutical and Biomedical Sciences
Abstract:Objective Compound Danshen Tablets (CDT), also known as Fufang Danshen Pian in China, has been commonly used to prevent and treat cardiovascular diseases in the clinic in Asia-Pacific region, especially in China. This study investigated the effects and possible mechanism of CDT against isoproterenol-induced myocardial infarction (MI) in rats. Methods Male rats were randomly assigned to six groups: control, model, isosorbide dinitrate (ISDN, 2.72 mg/kg, i.g.), low-dose CDT (0.315 g/kg, i.g.), medium-dose CDT (0.63 g/kg, i.g.), and high-dose CDT (1.26 g/kg, i.g.). After 10 consecutive days of administration, except for the control group, others were subcutaneously injected with 5 mg/kg isoproterenol for three consecutive days to establish MI models. Variables including electrocardiogram (ECG), cardiac function, infarct size, myocardium structure, and the activities of serum creatine kinase (CK), lactate dehydrogenase (LDH), cardiac troponin I (cTnI), nitric oxide (NO), endothelial nitric oxide synthase (eNOS), and brain natriuretic peptide (BNP) were determined. Results CDT significantly decreased infarct size, BNP level in myocardial tissues, and the concentrations of serum CK, LDH and cTnI. In addition, CDT could remarkably increase the levels of serum NO, eNOS and ameliorate myocardial injury. Conclusion CDT has endothelial protective effect against MI injury in rats by protecting cardiomyocytes, reducing myocardial infarct size, oxidative stress, the levels of serum myocardial enzymes (LDH and CK), cTnI, and BNP.